The efficacy of combined treatment with recombinant human tumor necrosis factor-alpha and 5-fluorouracil is dependent on the development of capillaries in tumor.

Source:http://linkedlifedata.com/resource/pubmed/id/2138912

Download in:

View as

General Info

PMID
2138912